Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CapnoSpot™ Pneumothorax Decompression Indicator

K-Number: K223625 · 2023-03-28

Decision Date2023-03-28
Product CodeGAA
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

CapnoSpot™ Pneumothorax Decompression Indicator is a medical device manufactured by Pneumeric, Inc.. It received FDA 510(k) clearance on 2023-03-28 under approval number K223625. The device is classified under product code GAA. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CapnoSpot™ Pneumothorax Decompression Indicator?

CapnoSpot™ Pneumothorax Decompression Indicator is a medical device that received FDA 510(k) clearance on 2023-03-28. It is manufactured by Pneumeric, Inc.. The 510(k) number is K223625.

When was CapnoSpot™ Pneumothorax Decompression Indicator approved by the FDA?

CapnoSpot™ Pneumothorax Decompression Indicator received FDA 510(k) clearance on 2023-03-28, under approval number K223625.

What company makes CapnoSpot™ Pneumothorax Decompression Indicator?

CapnoSpot™ Pneumothorax Decompression Indicator is manufactured by Pneumeric, Inc..

What is the FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator?

The FDA product code for CapnoSpot™ Pneumothorax Decompression Indicator is GAA.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.